Please assess the completion status of the following clinical trial:

Trial Title: Sonazoid-Enhanced Ultrasound in Detecting Sentinel Lymph Node in Patients With Cutaneous Melanoma

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Cutaneous melanoma with Breslow depth \> 1 mm or melanoma Breslow depth of 0.76 - 1.00 mm in setting of ulceration, extensive regression~* Mitotic rate \>= 1/mm\^2~* Presence of angiolymphatic invasion~* Deep positive margin~* No known allergies to contrast material~Exclusion Criteria:~* Pregnant or nursing~* Patients with known cardiac shunt~* Patients with class II heart failure or worse, per New York Heart Association (NYHA) classification~* Patients who have experienced an acute coronary syndrome or angina in the past 6 months~* Patients who have undergone coronary artery bypass grafting (CABG) or coronary stenting in the past 3 years~* Patients with evidence of moderate or severe cardiac valvular disease on echocardiogram~* Patients with evidence of moderate or severe pulmonary hypertension on echocardiogram~* Patients with stage II chronic obstructive pulmonary disease (COPD) or worse, per Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification~* Patients with hypersensitivity to sonazoid or one of its components~* Patients with hypersensitivity to egg or egg products, because sonazoid contains a chicken egg-derived surfactant (hydrogenated egg phosphatidylserine sodium)~* Patients who cannot consent for themselves

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Diagnostic (sonazoid, ultrasound imaging, SLNB) (Type: EXPERIMENTAL): Patients receive sonazoid ID and undergo ultrasound imaging. Patients also undergo standard of care SLNB.

Based on this trial design, predict the completion outcome and termination type (if applicable).